2.Chen Y, Clegg NJ, Scher HI. Anti-androgens a nd androgen-depleting therapies in prostate cancer: new agents for an established ta rget. The lancet oncology. 2009;10(10):981-91. Epub 2009/10/03. doi: 10.1016/S1470-2045(09)70229-3. PubMed PMID: 19796750; PubMed Central PMCID: PMC2935850. 3.Sartor AO, Tangen CM, Hussain MH, Eisenbe rger MA, Parab M, Fontana JA, et al. Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426). Cancer.